Headquartered just outside of Boston, Massachusetts, Melt Pharmaceuticals, Inc. is committed to the development and commercialization of a patented sublingual, needle and opioid-free procedural sedation and analgesic medication for preoperative use in human medical procedures. Melt Pharmaceuticals was spun out of Harrow Health in January 2019, after successfully completing our Series A financing.
ImprimisRx (a subsidiary of...
Headquartered just outside of Boston, Massachusetts, Melt Pharmaceuticals, Inc. is committed to the development and commercialization of a patented sublingual, needle and opioid-free procedural sedation and analgesic medication for preoperative use in human medical procedures. Melt Pharmaceuticals was spun out of Harrow Health in January 2019, after successfully completing our Series A financing.
ImprimisRx (a subsidiary of Harrow Health) and several leading ophthalmologists developed a cGMP compounded version similar to our lead candidate (Melt-100) that has been dispensed more than 100,000 times by over 400 ophthalmologists.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.